PURPOSE: To determine the accuracy of contrast material-enhanced subtr
action dynamic magnetic resonance (MR) imaging in the diagnosis of non
palpable breast tumors. MATERIALS AND METHODS: One hundred forty-three
patients underwent surgical biopsy of a nonpalpable breast lesion. Th
eir mammograms showed microcalcifications (n = 80), opacity (n = 52),
architectural distortion (n = 10), or asymmetric density (n = 1). All
patients underwent a preoperative gadolinium tetraazacyclododecanetetr
aacetic acid-enhanced subtraction dynamic study. Any early contrast en
hancement in the breast parenchyma was considered pathologic. RESULTS:
At histologic analysis, 27 intraductal carcinomas, 37 invasive carcin
omas, and 79 benign lesions were found. Dynamic MR studies showed earl
y contrast enhancement in 61 of 64 breast cancers (sensitivity, 95%) a
nd in 37 of 79 benign lesions (specificity, 53%). Two invasive lobular
carcinomas and one tubular carcinoma showed no early contrast enhance
ment. CONCLUSION: Subtraction dynamic MR imaging may be helpful to rul
e out malignancy in nonpalpable breast tumors.